Tharimmune Announces Initiation of Phase 1 Clinical Trial of TH104 and Provides Business Update
Phase 1 trial initiated to assess safety/tolerability and absolute bioavailability of TH104 with topline data expected in 2Q24Planning well underway for Phase 2 of TH104 in primary biliary cholangitis (PBC) patients suffering from moderate-to-severe ch…